Abstract
Introduction
Respiratory tract infections (RTI), comprising of upper respiratory tract infection (URTI) and lower respiratory tract infection (LRTI) are one of the most common infections, and are associated with considerable expenditure of currency of the nation. RTI's have been identified as major cause for restriction of activity and loss of attendance at school and work. URTI includes infection ranging from nose to trachea. LRTI includes infection of lung parenchyma, bronchus, bronchiole. [1, 2] Since RTI is one of the major reasons of antimicrobial agent/s (AMA/s) use on a large scale and because changes in AMA resistance pattern are a threat to its effective treatment, there is increasing concern about such unnecessary AMA prescription in the community. [3] Better drugs are available currently, patients are better educated, have greater expectations from health care systems and they use multiple health care systems, still drugs are not used properly according to the guidelines. Irrational use of AMAs has given rise to rapid emergence of resistance amongst microbes. [4] In the present scenario, AMAs are among the most common irrationally prescribed drugs.
The quality of health care depends on fulfillments of five properties of prescriptionjudicious, appropriate, safe, effective and economically feasible. [5] Inappropriate drug use includes misuse, overuse or underuse of a drug, either of which may lead to increased cost of health care, adverse effects or less therapeutic effect. There is mounting apprehension about ever increasing cost of health care, lack of rationality and homogeny in prescribing AMAs and finally, lack of monitoring and control over use of the same. Therefore, it is dire need of the hour, to promote rational use of AMAs, [6] which is tested lately by Drug Utilization (DU) studies. WHO defines DU as marketing, distribution, prescription and use of drugs in society, with special emphasis on the resulting medical, social and economical consequences. [7, 8] For DU, WHO laid down guidelines of ATC/DDD (Anatomical and Therapeutic Classification, Defined Daily Dose) which are used as drug utilization indicators. DDD was formulated as a means of study of drug sales, to serve as a proxy for drug consumption/utilization. The objective of ATC/DDD system is to serve as a tool for DU research, to favor improvement in drug use. [9, 10] Present study was conducted to analyze the prescribing pattern of antimicrobial drugs used in respiratory tract infections for rational use, in a tertiary care hospital of central India using combination of latest WHO DU indicators (ATC/DDD, PDD-Prescribed Daily Dose) and conventional method of comparing actually prescribed AMAs with WHO essential drug list. Such studies are useful improving quality of health care with minimal expenses.
Materials and Methods
It was an observational, retrospective, record based study, which was carried out from September 2013 to March 2014 at NKPS Institute of Medical Sciences and Research Centre, Nagpur, India. Permission for the study was obtained from Institutional Ethics Committee. WHO recommendations for DU were avidly taken into account and were strictly and consistently followed throughout the study. [11] After filtering numerous records through inclusion criteria, and exclusion criteria, a total of 400 records were finally analyzed. Inclusion criteria were patients with diagnosis of RTI and age above 15 years, irrespective of sex. Exclusion was Pregnancy, Age below 15 years, Inadequate clinical records/ data, Tuberculosis and Malignancy. All the records were retrieved from Medical Records Department (MRD), and all data was collected using a specially designed data collection sheet, which included important demographic characteristics like name, age, sex, occupation, diagnosis and prescription details including type of antibiotic, number of antibiotic per patient, route of administration, average hospital stay, culture and sensitivity reports, status of patient. Data was presented as n (%).Total AMAs prescribed were compared with WHO essential drug list and latest DDD values were substituted. [12, 13] th level codes-20 to 30 and they don't belong to same 4 th level, then they are classified using 50 series. DDD is defined as assumed average maintenance dose per day for a drug, used for its main indication in adults. DDD is assigned only to drugs that have an ATC code. It should be emphasized that the DDD is a unit of measurement and does not necessarily reflect PDD. DDD's/1000 inhabitants/day provide an estimate of the proportion of population within defined area, treated daily with certain drugs. PDD gives average daily amount of a drug that is actually prescribed. Formula for calculation of DDD's/1000 inhabitants/day is as under: [10] DDD's/1000 inhabitants/day = Total use of drug (mg) during study x 1000 DDD (mg) x duration of study (in days) x sample size
Results
Out of total 400 records analyzed 177 were males (44.2%) and 223 were females (55.7%). URTI accounted for 240 cases (60%), while LRTI was found in 160 cases (40%). Incidence of both was maximum in age group >45 years. Among URTI, most common etiology was nonspecific URTI (25%) and non-specific LRTI was the main culprit in LRTI (44.3%) Figure-1) . 
Figure-1: Number of FDCs of AMAs used
Amox-Amoxicillin, Clav-Clavulanic acid Ampi-Ampicillin, Sulb-Sulbactam Pipera-Piperacillin, Cefo-Cefoperazone Cotri-Cotrimoxazole, TMP-Trimethoprim SMX-Sulfamethoxazole Culture/sensitivity (C/S) was done in 20 patients (5%) and most common organism isolated was Staphylococcus aureus, followed by alpha hemolytic Streptococcus pneumoniae in URTI and Kleibsiella pneumoniae, followed by Pseudomonas in LRTI, which was found sensitive to amoxicillin+clavulanic acid, 3 rd and 4 th generation cephalosporins. AMA was changed in 10 patients after C/S report. Maximum cost was shared by macrolide (azithromycin), penicillins, cephalosporin. PDD was calculated for each drug and compared with DDD. DDDs/1000 inhabitants/day was also calculated for each drug and maximum value was found in azithromycin (2.8472) and least in ofloxacin (0.0138). PDD> DDD was found in amoxicillin (O & P), cefuroxime, azithromycin, doxycycline, cefixime + clavulanic acid, piperacillin + tazobactam, cotrimoxazole, levofloxacin(O), cefixime. PDD=DDD was 
Discussion
RTI is one of the most common cause for absenteeism from work and studies. [2] Prescribing drugs, is a multifactorial, complicated process which is influenced by socio-cultural factors like national drug policy, illiteracy, poverty, use of multiple health care systems, drug advice and promotion, sale of prescription drugs without prescription, competition in the medical and pharmacological market place and limited availability of independent, unbiased information. Improper use of drug echoes in the form of rise in cost of medical care, antimicrobial resistance, adverse effects, patient morbidity and mortality.
[14] In the present study, incidence of URTI was more as compared to LRTI. Most common perpetrator in URTI was non-specific URTI and nonspecific LRTI in LRTI. Incidence of both was found more in age group >45 years, other studies showing maximum incidence in younger age groups [15, 16] AMAs were prescribed in all, except in 15 patients. Most probable reason of such high rate of AMA use may be higher expectation of patient, and hence overprescribing by the physician to meet the same. [4] Average number of AMA/patient was one, which is a welcome sign, since least use of AMA in uncomplicated RTI is always expected. This findings were in contrast to other studies, which showed AMAs per patient to be 2,2.5,3,4. [17, 18, 19, 20] Most common AMA prescribed was azithromycin. Generic drugs were not prescribed at all. Of 15 AMAs prescribed, 9 were included in WHO essential drug list (60%), while other studies showed lower percentages. [6, 20] Most common route of drug administration was oral in URTI and parenteral in LRTI. C/S was done in 20 patients and most common organism isolate in URTI and LRTI was Staphylococcus aureus and Kleibsiella pneumoniae respectively, while other studies showed alfa hemolytic streptococci followed by Neisseria species. [16] Findings of comparison between DDD and PDD were in contrast with other studies. [1, 2] PDD can vary according to both, illness treated and national therapy traditions. For the anti-infectives, for instance, PDDs vary according to the severity of the infection. It should be noted that the PDD does not necessarily reflect actual dose consumed. It should also be emphasized that the DDD is a unit of measurement and does not necessarily reflect PDD. Doses for individual patient and patient groups will often differ from the DDD and will have to be based on individual characteristics of the patient-age, weight, and pharmacokinetic considerations. PDD/1000 inhabitants/day was maximum in azithromycin, which was similar in other study [1] , indicating that it is most favored AMA of choice amongst the physicians. The present study carries weightage since it combined latest WHO-DU indicators and conventional approach of DU study i.e. to tally actually prescribed AMAs with essential drug list, thus making it more comprehensive, covering maximum aspects of DU study. Our study had plethora of significant findings, which will probably help in designing prescribing strategies, such that they decrease unnecessary use of AMAs, thus decreasing cost of treatment and most importantly curb the spread of AMA resistance.
Conclusion
Patients with fever+cough+throat pain were prescribed with maximum AMAs, although it is well known that this symptoms are found mostly in viral fever, which do not benefit by use of AMAs, thus indicating their unnecessary use. This results in emergence of resistance, which prompts the physician to use newer AMAs, which are costly. Use of generic drugs should be encouraged or if possible, made compulsory. Physicians should be educated about rational drug prescribing, cost-effectiveness and adhering to established treatment guidelines, through CMEs, workshops, clinical meetings. Guidelines should be prepared by the concerned departments of the institute concerning judicious and effective use of AMA/s.
